Ikarian Capital, LLC LXRX — LEXICON PHARMACEUTICALS INC

Ownership history in Ikarian Capital, LLC  ·  7 quarters on record

AI Ownership Summary

Ikarian Capital, LLC reported LEXICON PHARMACEUTICALS INC (LXRX) in 7 quarterly 13F filings from 2024 Q4 through 2026 Q2. Peak portfolio weight reached 0.16% in 2024 Q4. The latest visible filing shows LXRX at 0.04% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this LXRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Ikarian Capital, LLC's position in LEXICON PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

LXRX was reported at 0.04% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.16% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

LXRX stock page Ikarian Capital, LLC fund profile Ikarian Capital, LLC full holdings
How Ikarian Capital, LLC held LXRX — position size vs. price
% of Fund (quarterly)    LXRX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 UNCHANGED — — — 164,674 — 0% 0.04% $395K 2026-08-14 $2.32
2026 Q1 UNCHANGED — — — 164,674 — 0% 0.02% $257K 2026-05-15 $2.23
2025 Q4 REDUCED 6.7% +35.6% ❌ 164,674 -11,805 -6.7% 0.01% $189K 2026-02-18 $1.32
2025 Q3 UNCHANGED — — — 176,479 — 0% 0.02% $238K 2025-11-14 $1.49
2025 Q2 REDUCED 87.6% +46.3% ❌ 176,479 -1,241,473 -87.6% 0.03% $167K 2025-08-14 $1.18
2025 Q1 REDUCED 8.5% +106.5% ❌ 1,417,952 -132,048 -8.5% 0.08% $653K 2025-05-15 $0.53
2024 Q4 INITIATED — — — 1,550,000 — — 0.16% $1.1M 2025-02-14 $0.78

🏢 Other funds also holding LXRX

As of 2026 Q2 — sorted by position size

Artal Group S.A. 3Y 7Y 45.15% Ishara Investments LP 2.24% Siren, L.L.C. 2.15% Sessa Capital IM, L.P. 3Y 7Y 0.76% Virtus Investment Advisers, LLC 3Y 7Y 0.1% ADAR1 Capital Management, LLC 0.08% R Squared Ltd 0.07% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.06% Headlands Technologies LLC 3Y 0.04% DIKER MANAGEMENT LLC 3Y 7Y 0.04%

FAQ About Ikarian Capital, LLC and LXRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Ikarian Capital, LLC reported owning LXRX?

Ikarian Capital, LLC reported LXRX across 7 quarterly 13F filings, from 2024 Q4 through 2026 Q2.

What was the largest reported LXRX position in Ikarian Capital, LLC's portfolio?

The largest reported portfolio weight for LXRX was 0.16% in 2024 Q4.

What is the latest reported LXRX position on this page?

The most recent filing on this page is 2026 Q2, when Ikarian Capital, LLC reported 164,674 shares, equal to 0.04% of portfolio, with an estimated market value of $395K.

What does the chart on this LXRX ownership page compare?

The chart compares Ikarian Capital, LLC's quarterly LXRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Ikarian Capital, LLC time their LXRX position?

Based on 13F filing dates vs. subsequent LXRX price moves, Ikarian Capital, LLC correctly timed 0 out of 4 reported position changes (0%). The annualised alpha on LXRX relative to SPY over the holding period was +309.1%.

← Back to Ikarian Capital, LLC Holdings